ULTRAGENYX PHARMACULTRAGENYX PHARMACULTRAGENYX PHARMAC

ULTRAGENYX PHARMAC

No trades
See on Supercharts

Price target

67.710.000.00%
The 19 analysts offering 1 year price forecasts for UP0 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 19 analysts giving stock ratings to UP0 in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


UP0 EPS for the last quarter is −1.39 CHF despite the estimation of −1.41 CHF. In the next quarter EPS is expected to reach −1.03 CHF. Track more of ULTRAGENYX PHARMAC financials and stay on top of what is up with the company.
In the next quarter ULTRAGENYX PHARMAC revenue is expected to reach ‪128.50 M‬ CHF. Check out ULTRAGENYX PHARMAC revenue and earnings and make informed decisions.
According to analysts, UP0 price target is 67.71 CHF with a max estimate of 109.04 CHF and a min estimate of 27.26 CHF. Check if this forecast comes true in a year, meanwhile watch ULTRAGENYX PHARMAC stock price chart and keep track of the current situation with UP0 news and stock market news.
We've gathered opinions of 19 analysts rating UP0 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.